Ying Ren
Jiangsu Key Laboratory Of New Drug Research And Clinical Pharmacy
Xuzhou, 221004, China
Xuzhou, 221004, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Targeting TRAF6 inhibits cystogenesis in autosomal dominant polycystic kidney disease.
Journal: Biochemical pharmacology
Published: February 12, 2025
Benzothiazole derivatives as histone deacetylase inhibitors for the treatment of autosomal dominant polycystic kidney disease.
Journal: European journal of medicinal chemistry
Published: January 24, 2024
Notch3 as a novel therapeutic target for the treatment of ADPKD by regulating cell proliferation and renal cyst development.
Journal: Biochemical pharmacology
Published: November 13, 2023
Structure-Affinity and Structure-Kinetic Relationship Studies of Benzodiazepine Derivatives for the Development of Efficacious Vasopressin V2 Receptor Antagonists.
Journal: Journal of medicinal chemistry
Published: February 03, 2023
Inhibition of deubiquitinase USP28 attenuates cyst growth in autosomal dominant polycystic kidney disease.
Journal: Biochemical pharmacology
Published: September 26, 2022
Antidepressant-like effects of ginsenoside Rg2 in a chronic mild stress model of depression.
Journal: Brain research bulletin
Published: February 06, 2017
A comparison of clinical characteristics and survival between diabetic nephropathy patients and non-diabetic nephropathy patients undergoing peritoneal dialysis
Journal: Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition
Published: July 21, 2012
Blood pressure variation of hypertensive diabetic nephropathy patients undergoing peritoneal dialysis
Journal: Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition
Published: July 21, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026